Critical Path Ventures
Overview
Critical Path Ventures is a French venture capital firm founded in 2022 that invests in deeptech startups at the seed stage, primarily in the physics, medicine, biotechnology, and robotics sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HighLife Medical | Sep 2026 | Early Funding | Co-investor |
| VSORA | Jul 2026 | VC Round | Co-investor |
| Prophesee | Jun 2026 | VC Round | Lead |
| 5h45 | - | Accelerator | Co-investor |
| Sonomind | May 2026 | Series A | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Critical Path Ventures based?
Critical Path Ventures is headquartered in Paris, France.
When was Critical Path Ventures founded?
Critical Path Ventures was founded in 2022.
How many portfolio companies does Critical Path Ventures have?
Critical Path Ventures has 6 portfolio companies in Caplight's dataset.
What are some companies in Critical Path Ventures's portfolio?
Portfolio companies visible on Caplight include HighLife Medical, VSORA, Prophesee, 5h45, Sonomind.
What was Critical Path Ventures's most recent investment shown here?
Critical Path Ventures's most recent investment in this portfolio sample was in HighLife Medical in 2026.
What sectors does Critical Path Ventures focus on?
Critical Path Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Energy & Sustainability, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does Critical Path Ventures focus on?
Critical Path Ventures typically invests at the Early stage.
What is Critical Path Ventures's AUM?
Critical Path Ventures's assets under management are estimated between $21.6M and $21.6M.